Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Sensors track apathy in dementia patients

NCT ID NCT02496312

Knowledge-focused Sponsor: Institut National de la Santé Et de la Recherche Médicale, France Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This pilot study tested whether wearable sensors can accurately measure apathy in people with frontotemporal dementia. Researchers monitored 14 participants' movements and behaviors in real-life situations. The goal was to see if technology could provide a more objective way to assess apathy compared to standard questionnaires.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could lead to better ways to measure apathy in dementia patients using wearable sensors.
What could go wrong
This is a very small pilot study with only 14 participants, so results may not apply widely. It is designed to test measurement methods, not to treat or cure the condition.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

14 people

The number who actually took part.

Started

Jul 2015

Finished

Oct 2015

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

20 to 85 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Diagnosis of Frontotemporal Dementia (FTD) according to diagnostic criteria reported by Rascovsky et al. (2011). * Understanding of the instructions and capacity to realize the cognitive tasks. * Capacity to read, to understand and to sign legal document of information * Capacity for informed consent for research, capacity to sign consent * MMSE score \> 20 * Absence of other cerebral pathology. * Absence of psychiatric disease interfering with the assessment of the tests * Absence of excessive psychotropic use * Access to National Healthcare Insurance * Accompanied with a caregiver Exclusion Criteria: * Excessive psychotropic use * Incapacity or refusal to realize the experimental tasks * Subject deprived of freedom by an administrative or court order * Subject under legal protective measure. * Incapacity for informed consent for research * Participation in another biomedical research * Airway obstruction risk * Reduction of activity not attributable to another chronic pathological condition

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for APATHY are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Behavior frontotemporal dementia Lethargy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

APATHY Behavior Frontotemporal dementia

Contacts and locations

Locations

  • CIC de Neurosciences, ICM, hôpital de la Pitiè Salpétrière

    Paris, 75013, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.